These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1956490)

  • 1. Establishing the relationship between complement activation and stimulation of phagocyte oxidative metabolism in hemodialyzed patients: a randomized prospective study.
    Descamps-Latscha B; Goldfarb B; Nguyen AT; Landais P; London G; Haeffner-Cavaillon N; Jacquot C; Herbelin A; Kazatchkine M
    Nephron; 1991; 59(2):279-85. PubMed ID: 1956490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood.
    Nguyen AT; Lethias C; Zingraff J; Herbelin A; Naret C; Descamps-Latscha B
    Kidney Int; 1985 Aug; 28(2):158-67. PubMed ID: 3834227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane?
    Iatrou C; Afentakis N; Nomikos T; Dinas C; Stavropoulos-Giokas C; Antonopoulou S
    Nephron; 2002 May; 91(1):86-93. PubMed ID: 12021524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocompatibility of different hemodialysis membranes: activation of complement and leukopenia.
    Wegmüller E; Montandon A; Nydegger U; Descoeudres C
    Int J Artif Organs; 1986 Mar; 9(2):85-92. PubMed ID: 3699914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
    Chenoweth DE; Cheung AK; Henderson LW
    Kidney Int; 1983 Dec; 24(6):764-9. PubMed ID: 6609269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocytes, eosinophils and complement function during hemodialysis with polysulphone and polymethylmethacrylate membranes: comparison with cuprophan and polyacrylonitrile.
    Bergesio F; Monzani G; Manescalchi F; Boccabianca I; Passaleva A; Frizzi V
    Blood Purif; 1988; 6(1):16-26. PubMed ID: 3345242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-neutrophil interactions during hemodialysis: a proposed biocompatibility approach.
    Stuard S; Bonomini M; Settefrati N; Albertazzi A
    Int J Artif Organs; 1998 Feb; 21(2):75-82. PubMed ID: 9569128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocompatibility of hemodialysis membranes: interrelations between plasma complement and cytokine levels.
    Varela MP; Kimmel PL; Phillips TM; Mishkin GJ; Lew SQ; Bosch JP
    Blood Purif; 2001; 19(4):370-9. PubMed ID: 11574733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limulus amebocyte lysate reactivity, complement activation, and patients' symptoms. Comparison of dialyzer membranes.
    Moss AH; Hamrick RM; Shen SH
    ASAIO Trans; 1989; 35(4):812-5. PubMed ID: 2611049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of complement by hemodialysis membranes: polyacrylonitrile binds more C3a than cuprophan.
    Cheung AK; Parker CJ; Wilcox LA; Janatova J
    Kidney Int; 1990 Apr; 37(4):1055-9. PubMed ID: 2342244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-membrane interactions during haemodialysis with cellulose and synthetic membranes.
    Woffindin C; Hoenich NA
    Biomaterials; 1988 Jan; 9(1):53-7. PubMed ID: 3126842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement C3 and C5 degradation products during hemodialysis treatment: study of an index of membrane bioincompatibility.
    Freyria AM; Leitienne P; Veysseyre CN; Bringuier JP; Traeger J
    Int J Artif Organs; 1988 Mar; 11(2):111-8. PubMed ID: 3259552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive oxygen product formation by human neutrophils as an early marker for biocompatibility of dialysis membranes.
    Rosenkranz AR; Templ E; Traindl O; Heinzl H; Zlabinger GJ
    Clin Exp Immunol; 1994 Nov; 98(2):300-5. PubMed ID: 7955536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenge of phagocyte metabolism by extracorporeal circulation and membrane contact. A biocompatibility test.
    Vanholder RC; Dhondt A; Ringoir SM
    ASAIO Trans; 1988; 34(3):543-5. PubMed ID: 3143383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activation during hemodialysis: clinical observations, proposed mechanisms, and theoretical implications.
    Chenoweth DE
    Artif Organs; 1984 Aug; 8(3):281-90. PubMed ID: 6332607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved biocompatibility by modified cellulosic membranes: the case of hemophan.
    Lucchi L; Bonucchi D; Acerbi MA; Cappelli G; Spattini A; Innocenti M; Castellani A; Lusvarghi E
    Artif Organs; 1989 Oct; 13(5):417-21. PubMed ID: 2803049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients.
    Tarng DC; Huang TP; Liu TY; Chen HW; Sung YJ; Wei YH
    Kidney Int; 2000 Aug; 58(2):790-9. PubMed ID: 10916104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The polycarbonate hemodialysis membrane: neutrophil, platelet, complement and chemiluminescence kinetics during first and second use.
    Heierli C; Markert M; Frei J; Lambert PH; Wauters JP
    Blood Purif; 1986; 4(1-3):82-7. PubMed ID: 3730165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphonuclear oxygen free radical production and complement activation induced by dialysis membranes as assayed in an experimental model.
    Cappelli G; Lucchi L; Bonucchi D; Cenci AM; Montagnani G; De Palma M; Lusvarghi E
    Blood Purif; 1989; 7(6):293-300. PubMed ID: 2611000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.